Chronos Archive seal

Review checklist: Jesse Owens (HR-ML042)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check screening eligibility and the shared decision-making elements, the Lung-RADS 4X work-up, EBUS staging (cT1c N1, stage IIB), the choice of three cycles of nivolumab with carboplatin and pemetrexed before surgery and of no adjuvant therapy after a major pathologic response, the predicted postoperative lung function, the handling of the grade 1 TSH rise, the exclusion of pneumonitis at the sick visit, and varenicline started after the diagnosis.
provenance reviewnot_startedHe died in 1980; the recent-death rule does not apply. Claims rest on four Ohio State University Libraries exhibit pages and the Ohio State University Archives biographical clipping file. The smoking history, the documented adenocarcinoma of the left lung and the dates of admission and death are D; the screening, stage, biomarkers and treatment are synthetic. His daughters are not named.
safe messaging reviewnot_startedTobacco claims are marked sensitive. No mental health claim is made; mood screens are synthetic and below the threshold for a safety assessment. His death is recorded once, without detail. No relative is given a role in the modern episode; the president of the 1930s is not named.

Judgment calls (dossier editorial resolutions)

  1. Recent-death rule. He died in 1980, so the rule does not apply. The claims are still limited to what the fetched sources state.
  2. Sources not used. The New York Times obituary (blocked), Britannica (blocked), Olympics.com (timed out) and the Smithsonian pages could not be read, and William J. Baker’s biography was not read; none is cited. The four gold medals rest on the Ohio State University Libraries and the archival clippings. The accounts on secondary websites that his cancer was “extremely aggressive and drug-resistant” were not found in a reliable fetched source and are not claimed. The histology (adenocarcinoma), the side (left lung) and the word “inoperable” come from contemporary newspaper clippings in the Ohio State University Archives, read by text extraction from scans; the quoted phrases were checked against the extracted text.
  3. Conflicts. The Ohio State University Libraries say he was the last of ten children; the clippings and his own account say nine. Both are recorded in CLM-0001. One clipping gives his time of death as 5:40 a.m. and another as 3:40 a.m.; neither is used. The clippings place his home in Paradise Valley and the Phoenix area; the library says Scottsdale; the record says the Phoenix area.
  4. Smoking history. “A pack-a-day smoker for the past 35 years” gives about 35 pack-years, which the modern record uses; the age at which he started is not documented. The claim is marked sensitive.
  5. Index age and dates. The synthetic date of birth is September 12, 1960 (shift 47 years). The index visit on May 11, 2026 maps to May 11, 1979, when he was 65 and living in the Phoenix area, seven months before the documented admission in December 1979. All visits map to May to October 1979, within his lifetime and before his documented diagnosis. Index age 65 was chosen, rather than 66, so that a full course of care fits between the index date and November 1, 2026 while staying before the documented diagnosis; he turns 66 before the wellness visit. The visits are not a claim about his real care in 1979.
  6. The teaching contrast. His documented cancer was an inoperable adenocarcinoma of the left lung found after breathlessness began. The modern episode finds an adenocarcinoma of the left upper lobe by low-dose screening while it is still stage IIB and resectable, because he meets the 2021 USPSTF criteria. This is a teaching choice, not a claim about what screening could have done in his lifetime; low-dose CT screening did not exist then. The synthetic history that no clinician had offered him screening illustrates the documented under-offer of screening to Black smokers and is not a claim about his real care.
  7. Presenting problem. The Lung-RADS 4X nodule (R91.1) is the presenting finding at intake and is resolved at the diagnosis visit on May 26, 2026, when the adenocarcinoma (C34.12, both_with_link to the documented diagnosis) is recorded. He is asymptomatic apart from a long-standing smoker’s cough, so he is a screening candidate rather than a diagnostic patient; the intake documents show only the same-day screening CT and the plan.
  8. Treatment choice. Stage IIB (cT1c N1 M0) with no EGFR or ALK alteration: three cycles of nivolumab with carboplatin and pemetrexed before surgery (CheckMate 816) were chosen over surgery first followed by adjuvant therapy, because treatment before surgery gives a pathologic response to guide later decisions and the ability to start systemic therapy at once. Perioperative regimens that add immunotherapy after surgery are alternatives; after a major pathologic response with negative nodes the record has him choose surveillance after discussion. These choices are clinical judgment calls for review. KRAS G12C is recorded for use only if the cancer recurs.
  9. Palliative care. Specialist palliative care was not requested, because the cancer was treated with curative intent and caused no symptom burden; symptom, distress and mood screening at each visit and advance care planning at the wellness visit stand in its place. This is recorded as not indicated in the monitoring table.
  10. Tobacco. He smokes at intake and starts varenicline at the diagnosis visit, quitting on the day of cycle 1. Nicotine dependence (F17.210) is resolved at the visit after surgery and replaced by nicotine dependence in early remission (F17.211, both_with_link). F17 codes do not require a safety assessment, and every mood screen is below threshold.
  11. Synthetic clinical picture. All visits, results, imaging, pathology, stage, biomarkers (PD-L1 40 percent, KRAS G12C), doses (carboplatin 525 mg by the Calvert formula; pemetrexed 970 mg for a body surface area of 1.94 m2), the operation and its pathology (ypT1a N0, R0, 6 percent viable tumor), his height (178 cm) and weights are synthetic. Pulmonary function values are coded with the imaging category, as in other records; the DLCO percent predicted and the predicted postoperative values are in note text.
  12. Sick visit. A rhinovirus cold on day 13 of cycle 2 (J06.9), chosen because a new cough on a checkpoint inhibitor must be distinguished from immune-related pneumonitis and from neutropenic infection, which teaches the warning-sign pathway and insinuates no undocumented real diagnosis. The exposure is attributed to children at a youth club, not to any relative.
  13. Annual wellness visit. A subsequent annual wellness visit at 66 (HCPCS G0439 and CPT 99497 in plain text): influenza, COVID-19, RSV and the first zoster vaccines; PCV20 already given before treatment; abdominal aortic aneurysm screening met by the staging CT; lung cancer screening replaced by surveillance; a lipid panel ordered because of coronary calcification on the screening CT; and advance care planning with an unnamed agent.
  14. Focused visits. The four chronic-care follow-ups (diagnosis and consultation, cycle 2, after three cycles, and six weeks after surgery) are documented as focused visits on the NCCN guideline, the CMID lung cancer monograph, ASCO immune-related adverse event guidance, ACCP staging and physiologic evaluation guidance, and the USPSTF tobacco recommendation. Synthetic findings introduced: a grade 1 subclinical thyroiditis on nivolumab (TSH 6.8 with normal free T4 after three cycles, 4.6 six weeks after surgery, untreated), and the state after lobectomy (Z90.2). One protocol deviation is recorded instead of an invented result: the morning cortisol that the CMID schedule calls for before each immunotherapy infusion was not drawn at cycle 2 because the order set lacked it; no symptoms or signs of adrenal insufficiency; corrective action: cortisol added to the standing order set, drawn before surgery (12.9 mcg/dL, normal), closing the deviation.
  15. Consultation. The thoracic oncology referral and the consultation by Ngozi Halvorsen-Pierce, MD (a fictional consultant), on the diagnosis day, are S. The consultant answers the six referral questions in line with what the record shows afterwards: stage IIB on systematic EBUS staging; three cycles of nivolumab with carboplatin and pemetrexed, restaging and thoracoscopic lobectomy; EGFR and ALK excluded first; fitness for lobectomy from predicted postoperative values; varenicline; surveillance after a major pathologic response; and no specialist palliative care for now.
  16. Equity. The teaching objective, the intake plan and the consultation cite documented disparities: earlier screening criteria that missed many Black smokers, lower completion of screening by Black patients after referral, and lower rates of surgery for Black patients with early lung cancer. A nurse navigator tracks time to treatment.
  17. Real people. His wife appears by name only in the claims (CLM-0007); his daughters are not named. No relative is given a decision, a statement or a health fact in the modern episode, and the health care agent is unnamed. His coaches appear only in the claims. The president of the 1930s and other figures with records in the dataset are not named. The historical physicians named in the clippings are not named in the record.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-06-24
Progress note 03 (C-CDA)
Morning cortisolBaseline and before each immunotherapy infusion (CMID); for symptomsMissed: the CMID schedule calls for cortisol before each infusion, but the cycle 2 order set did not include it and it was not drawn. No harm is expected: he has no fatigue beyond the days after chemotherapy, no low blood pressure, low sodium or dizziness. Corrective action: cortisol added to the standing order set for cycle 3 and to the blood tests before surgery

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-05-26
Progress note 02 (C-CDA)
Self-managementPulmonary rehabilitation (prehabilitation)ReferredTwice-weekly program from next week, alongside chemotherapy
2026-09-30
Progress note 06 (C-CDA)
Self-managementPulmonary rehabilitation after lung resectionReferredStarts next week
2026-10-21
Progress note 07 (C-CDA)
PreventionLipid panel and statin assessmentOrderedCoronary calcification on CT; fasting lipid panel and A1c ordered

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

ClaimGradeStatement
CLM-0009DHe smoked cigarettes for decades: at his death newspapers described him as a pack-a-day smoker for the past 35 years, and his doctors said he had smoked about a pack a day. The Ohio State University Libraries call him a lifetime smoker.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-06-24Glucose101 mg/dL (high)High
2026-08-05Hemoglobin12.8 g/dL (low)Low
2026-08-05TSH6.8 mIU/L (high)High
2026-09-30Hemoglobin13.4 g/dL (low)Low
2026-09-30TSH4.6 mIU/L (high)High
2026-07-06Hemoglobin13.1 g/dL (low)Low